Peripheral cannabinoid receptor, CB2, regulates bone mass.
about
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoA cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossIs lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabinoids in health and diseaseCrucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic painBeta-caryophyllene is a dietary cannabinoidThe endocannabinoid system as an emerging target of pharmacotherapyThe cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationSpecies-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersSmall Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentMinireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulationEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsSpontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin TreatmentWhat we know and do not know about the cannabinoid receptor 2 (CB2)The CB2 receptor and its role as a regulator of inflammationAutomated discovery of functional generality of human gene expression programsEmerging targets in lipid-based therapyThe genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized miceVariation in within-bone stiffness measured by nanoindentation in mice bred for high levels of voluntary wheel running.Preparation of stable isotope-labeled peripheral cannabinoid receptor CB2 by bacterial fermentation.The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channelsIn vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid.Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.CB2: a cannabinoid receptor with an identity crisisTreatment with a cannabinoid receptor 2 agonist decreases severity of established cystitisCB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and massThe promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease.Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study.Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channelsCB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Cannabinoid receptors: where they are and what they do.Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.Depression induces bone loss through stimulation of the sympathetic nervous system.Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists.Impaired osteoblast function in GPRC6A null mice.Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings
P2860
Q24322122-E65D094F-48A2-423A-A189-977C8699B63EQ24615787-D132AB79-8F66-4B3F-90BF-E25B636BAA11Q24633122-45CCD148-FD94-4995-BAFB-98EB21A4CB67Q24633884-A6D59AE0-7C90-4870-86FC-BFC262B3BA4CQ24634161-CE94A025-E806-4E2F-B7DA-F38A4373AB9DQ24645478-93FA0FEB-7B41-4A0B-AB1C-BC9D48604B40Q24648473-6AA48F39-6CD9-4E06-9B80-6B28159E0AD8Q24651712-708A2E78-C102-483C-91AE-E602C9656183Q24673335-004F6EA1-DABD-4C62-84FF-A578E86F9D71Q26776241-BBCDC456-98C7-4853-A0B3-78B96D4D14F6Q26829111-08CC11A1-6DF5-401E-B195-A227079755E4Q27009220-A3B9AD7E-AB25-45FE-AF7A-3B72F3E64660Q27324350-A7E00314-6E95-403A-A542-2B0235F0D547Q27686851-63267F93-0342-4981-84EE-C661C1760131Q28066700-CD8B53C5-3C76-46C9-923A-FFBCE6B71E8CQ28469275-DAFBC290-32C3-4741-9F1B-9BEB650A3FBCQ28655456-2C4D65CD-F36B-4676-9F87-7B9AABAC5A5EQ33562189-95174696-3543-4885-B064-CDD3BC769CF6Q33596632-645E7FE9-08FD-42FD-9D84-A174159956D3Q33684429-F7EA2D77-4AC9-4556-A03D-86C208C7CEEDQ33790150-0E220F8E-45A3-4AAE-8A76-1E2B27F82E14Q33944886-35D53C93-8292-4EE2-9412-9E4E90FC0417Q33997873-3C1D8EBE-098A-4C22-96F2-9BF0A2D0DA21Q34098185-5C4FB799-B456-4600-BFD7-D86EB19C9C2DQ34176058-D91DE8AA-41C3-47FC-AF39-C9D850229276Q34186015-413DF612-DDB6-4260-9CBC-A3B737BEDEBBQ34199882-CCE7FB96-018A-4155-BA00-348F8A053A01Q34393890-E05F6D22-647A-4B2F-901F-36EDC203BB4FQ34402180-912CE303-B4D2-4199-9BA0-15F516C45391Q34468292-52F27CAD-2D40-46D8-93AB-62514A06AF6AQ34626997-AC447709-22D8-4BE7-B9B6-DFF4B783C11AQ34649067-F7B34D78-B796-4272-915A-CC5F368D7ED1Q34733645-4B0666E6-4A5C-48BD-AFEE-EC9B0A08B48FQ34772274-949FA4BF-957B-46D8-BAB9-7EB68611A28CQ35018622-1DEE0A15-D7E4-4FBE-9460-2E3282FEAF3CQ35130779-C146F276-2A78-47D0-BEB8-F3EEC48FE6ADQ35147183-A0EFBEF4-B067-4393-B628-323C1815F5DCQ35156186-9D131338-F138-4C7A-A763-FAD2766C4924Q35184435-8E0804FB-F9E9-4734-A507-C475E37F1FC6Q35193292-50D88050-0F2D-42FD-9D37-5F0A4CF7758A
P2860
Peripheral cannabinoid receptor, CB2, regulates bone mass.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Peripheral cannabinoid receptor, CB2, regulates bone mass
@nl
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@ast
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@en
type
label
Peripheral cannabinoid receptor, CB2, regulates bone mass
@nl
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@ast
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@en
prefLabel
Peripheral cannabinoid receptor, CB2, regulates bone mass
@nl
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@ast
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@en
P2093
P2860
P921
P3181
P356
P1476
Peripheral cannabinoid receptor, CB2, regulates bone mass.
@en
P2093
Andreas Zimmer
Baruch Frenkel
Esther Shohami
Joseph Tam
Karen Wright
Malka Attar-Namdar
Meirav Fogel
Meliha Karsak
Nathalie Leclerc
P2860
P304
P3181
P356
10.1073/PNAS.0504187103
P407
P577
2006-01-09T00:00:00Z